Clinical Trials Directory

Trials / Completed

CompletedNCT07381348

Determination of Metabolomic Profile Differences in Possible Sarcopenia Accompanying Fibromyalgia Syndrome in Women

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
Female
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to determine the serum metabolome profile differences in the presence of possible sarcopenia in patients with fibromyalgia and to compare them with healthy individuals. In this way, it is aimed to contribute to the knowledge about the pathophysiology, diagnosis and treatment of these diseases.The main questions it aims to answer are: * Is there a difference in blood metabolite levels and metabolic pathways in fibromyalgia syndrome and possible sarcopenia accompanying fibromyalgia syndrome? * Based on these identified differences, can biomarkers be determined for these diseases?

Detailed description

After being informed about study and potential risks, all patient giving written informed consent will undergo screening period determine eligibility for study entry. Participants will be divided into three groups: those with fibromyalgia syndrome and probable sarcopenia, those with fibromyalgia syndrome and no probable sarcopenia, and healthy people. Presence of probable sarcopenia and sarcopenia will be determined by using SARC-F scale, hand grip strength measurement with hand dynamometer, muscle mass measurement with Bioimpedance Analysis, anthropometric measurement, walking speed measurement in patients with fibromyalgia diagnosis.The serum metabolome profiles of the three groups will be compared.

Conditions

Timeline

Start date
2022-06-01
Primary completion
2022-11-10
Completion
2023-05-30
First posted
2026-02-02
Last updated
2026-02-02

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07381348. Inclusion in this directory is not an endorsement.